Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled corticosteroids for the treatment of COVID-19.

Published October 20, 2021 | Version v3

Other Open

Notes

funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project "CEOSys"

Name	Size	Download all
2021-10-13_RoB2 assessments for Cochrane Reviews Inhaled corticosteroids for the treatment of COVID-19.xlsm md5:4106567031837c8010dde3c625bc409d	696.2 kB	Download
2022-01-09_RoB2 assessments for Cochrane Reviews Inhaled corticosteroids for the treatment of COVID-19.xlsm md5:af20298cea79025abf8c67ee36d4e83f	649.2 kB	Download
2022-01-11_RoB2 assessments for Cochrane Reviews Inhaled corticosteroids for the treatment of COVID-19.xlsm md5:19b592919164c417630c068fbef58322	642.3 kB	Download